Ubs Group Ag Chimerix Inc Put Options Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CMRX
# of Institutions
75Shares Held
36.7MCall Options Held
182KPut Options Held
108K-
Ra Capital Management, L.P. Boston, MA8.8MShares$38.5 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.04MShares$17.7 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.77MShares$16.5 Million0.32% of portfolio
-
Monaco Asset Management Sam2.82MShares$12.4 Million1.45% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.56MShares$11.2 Million0.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $384M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...